Identifiers
Database identifiers and provenance.
- Ligand ID
TAC- PDB
1i97- UniProt (similar protein)
P17291- Target protein
- PA4267
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 444.4
- LogP ≤ 5 -0.21
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 181.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)C(C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)OC[C@]1(c2cccc(c2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)C(C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O
InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15?,21+,22-/m0/s1InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15?,21+,22-/m0/s1
OFVLGDICTFRJMM-KLDQZYHPSA-NOFVLGDICTFRJMM-KLDQZYHPSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00163' 'PF00380' 'PF01479
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand TAC →
- PDB RCSB structure 1i97 →
- UniProt UniProt P17291 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “TAC”) →
Other binders for this protein
Quick navigation to other ligands bound to PA4267.
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).